Currently Viewing:
Psych Congress 2018
Considerations for Clinicians Looking to Advise Patients About Cannabis
October 25, 2018
Dr W. Clay Jackson on the Prevalence of Clinician Burnout
October 25, 2018
Dr Mark Zimmerman on How Depression Severity Is Measured
October 25, 2018
Challenges of Treating Postpartum Depression
October 26, 2018
Dr Michael Thase Discusses Treating Major Depressive Disorder
October 26, 2018
Dr Joseph McEvoy Outlines Barriers to Mitigating Internal Stigma Surrounding Mental Illness
October 26, 2018
Currently Reading
Survey of Patients With Depression Finds Many Say Antidepressants Unhelpful
October 27, 2018
As Hurricanes, Shootings Rise, Psychiatrist Discusses Mental Health in the Aftermath
October 27, 2018
Should Antidepressants Be Used in Bipolar Depression? A Pro-Con Debate
October 28, 2018
Ten Drug Combinations That Show the Risks of Psychiatric Polypharmacy
October 28, 2018
Phase 3 Study of ALKS 3831 Indicates Schizophrenia Drug Shows Benefit
October 28, 2018
Dr Michael First: Challenges With Correctly Diagnosing ADHD, Bipolar Disorder
October 28, 2018
Dr John Kane on the Importance of Patient, Family Engagement in Schizophrenia
October 28, 2018
Psychiatrist With Multiple Relatives With Autism Shares Treatment Journey
October 29, 2018
Dr Michael Thase on the Prevalence of Stigma Surrounding Major Depressive Disorder
November 19, 2018
Dr W. Clay Jackson: Specialties With the Highest, Lowest Clinician Burnout
November 21, 2018
Dr W. Clay Jackson: Clinician Burnout Impacts Both Personal and Patient Outcomes
December 02, 2018
Dr Michael Thase Outlines Developments in the Pathophysiology of Major Depressive Disorder
December 05, 2018
Dr W. Clay Jackson Discusses Identifying, Addressing Clinician Burnout
December 18, 2018
Dr Michael Thase: Patient Characteristics, Biomarkers That Guide Treatment for MDD
December 21, 2018

Survey of Patients With Depression Finds Many Say Antidepressants Unhelpful

Allison Inserro
A survey of people with depression seeking information about their perspectives and experiences living with the disease found that even though most took antidepressants, 42% of patients did not find them helpful, according to a poster presented at Psych Congress 2018.
A survey of people living with depression seeking information about their perspectives and experiences living with the disease found that even though most took antidepressants, 42% of patients did not find them helpful, according to a poster presented at Psych Congress 2018.

The online survey was given between December 2017 and March 2018 via the website, newsletter, and social media platforms of Depression and Bipolar Support Alliance (DBSA), a patient support group. The patient perspectives of disease, overall wellbeing, and treatment outcomes are key to understanding the challenges that come with their disease, according to the authors.

Of the 435 participants, 83% were female, the mean age was 44, and most reported moderate depression (43%). Participants were included in the survey if they had a diagnosis of major depressive disorder (MDD), but excluded if they had both MDD and bipolar disorder.

The survey sought to gain an understanding of the experiences, feelings, health-related quality of life (HRQoL), and overall wellbeing of patients, and to see how a clinical measure of depression (the Patient Health Questionnaire-9 [PHQ-9]) correlated with patients’ self-reported resiliency, HRQoL, wellbeing, and self-perceived depression.

In addition to the PHQ-9, patients were also asked to use other measures, including the  Short Form 12-item (SF-12) measure of HRQoL, the World Health Organization 5-item (WHO-5) measure of overall wellbeing, and the Connor-Davidson Resilience Scale (2-item version; CD-RISC2) measure of resilience.

The mean duration of depression was 25.2 years, 69% reported physical pain, and 52% reported that over the past 2 weeks they had lost interest in doing things on more than half of the days.

Most patients don’t get a complete response from medication, noted Amy K. O’Sullivan, head of health economics and outcomes research at Alkermes, which funded the study.

In one study, between 50% and 70% of patients with depression experienced only partial response to medication. Only 30% of patients achieved complete response. In the Sequenced Treatment Alternatives to Relieve Depression study (STAR*D), the landmark trial run by the National Institute of Mental Health, more than half of patients failed to achieve remission after first-line therapy, and about 70% did not achieve response after second-line treatment.

In the survey, among those currently using prescription medications, the most common therapy classes used were selective serotonin reuptake inhibitors (48%), dopaminergic/nonadrenergic agents (34%), serotonin and norepinephrine reuptake inhibitors (33%), and atypical antipsychotics (22%).

While 78% of participants take medications for depression, only 42% of these find them helpful. People living with depression reported problems coping with routines of everyday life, managing symptoms, and a sense of failure in being self-sufficient.

O’Sullivan said the survey results line up with these earlier study results and show the difficulty that patients face.

“What does that mean for their life?” she asked. Also, it raises the question, “what are they looking for in a treatment?”

Interestingly, the wellness strategy seen as most helpful by patients was getting enough quality sleep (76%) followed by playing with a pet (59%), or getting exercise (58%).

The number one desired improvement patients wanted from their depression treatment was improvement in emotional well-being. The symptom improvement patients ranked first was a reduction of suicidal thoughts and feelings.

“The take home from this is that we have a long way to go when treating for depression to a point where we can make a difference,” said O’Sullivan.

Reference

O’Sullivan AK, Benson H, Partham A, et al. Perspectives and experiences of individuals living with depression: severity of condition, wellbeing, and quality of life. Presented at Psych Congress 2018, October 25-28, 2018, Orlando, Florida. Poster 129.

 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up